Showing results (1-10 of 80) with videos related to
Sort By:
Pageof 8
Stem Cell Reviews and Reports|August 17, 2025
Challenging Reward Structures and Organizational Cultures that Propagate Stem Cell HyperboleAnnie Trinh, Leigh TurnerCell Stem Cell|May 29, 2020
Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19Leigh TurnerTrends in Molecular Medicine|May 7, 2015
US stem cell clinics, patient safety, and the FDALeigh TurnerKennedy Institute of Ethics Journal|October 28, 2003
Zones of consensus and zones of conflict: questioning the "common morality" presumption in bioethicsLeigh TurnerPerspectives in Biology and Medicine|May 29, 2018
The US Direct-to-Consumer Marketplace for Autologous Stem Cell InterventionsLeigh TurnerDeveloping World Bioethics|March 17, 2012
News media reports of patient deaths following 'medical tourism' for cosmetic surgery and bariatric surgeryLeigh TurnerRegenerative Medicine|July 20, 2017
ClinicalTrials.gov, stem cells and 'pay-to-participate' clinical studiesLeigh TurnerGlobalization and Health|October 15, 2011
Canadian medical tourism companies that have exited the marketplace: Content analysis of websites used to market transnational medical travelLeigh TurnerStem Cell Reports|May 28, 2021
ISSCR's Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventionsLeigh TurnerCell Stem Cell|November 5, 2021
The American stem cell sell in 2021: U.S. businesses selling unlicensed and unproven stem cell interventionsLeigh TurnerPageof 8